Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and investment success through turning break-through science into approved medicines or medical products.
We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines.
As entrepreneurs and experienced, pragmatic investors, we bring the intellectual capital of our well connected team to support each investment. We work in close alignment with our management teams, and partner with them to realise their vision - achieving superior financial returns by bringing innovation to patients.
The companies in which we have invested since the year 2000 have discovered and developed, fourteen approved medicines and products - to the benefit of patients, physicians and our investors.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2005
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Advent Life Sciences founded?
Advent Life Sciences was founded in 2005.
What industry is Advent Life Sciences in?
Advent Life Sciences operates in Venture Capital and Private Equity Principals. Find similar Venture Capital and Private Equity Principals investors on gritt.io.
Where is Advent Life Sciences based?
Advent Life Sciences is headquartered in London | Investing Transatlantically, United Kingdom.
Find investors for your startup like Advent Life Sciences
Gritt sends AI-personalised outreach to each investor — from your Gmail
